Skip to main content
OpenTrials

Clinical trial condition

Genital Neoplasms, Male

Explore clinical trials studying Genital Neoplasms, Male. Study availability and eligibility vary by location and protocol.

5,037 public trials 1,027 recruiting studies
Refine in advanced search Browse all conditions

Genital Neoplasms, Male trial results

Completed

ADXS31-142 Alone and in Combination With Pembrolizumab (MK-3475) in Participants With Previously Treated Metastatic Castration-Resistant Prostate Cancer (mCRPC)

NCT02325557

Conditions
Cancer, Genital Diseases, Genital Diseases, Male, +9 more
Locations
  • Recruiting San Francisco, California, United States
  • University of Colorado Health Sciences Center (UCHSC) Aurora, Colorado, United States
  • Recruiting Rockville, Maryland, United States
  • Recruiting Towson, Maryland, United States
View Trial Details
Completed

The "PC-LIGHT" Study

NCT03419585

Conditions
Behavior, Behavioral Symptoms, Depression, +16 more
Locations
  • Northwestern Univeristy Feinberg School of Medicine Chicago, Illinois, United States
View Trial Details
Completed

Hypofractionated Radiosurgery for Localised Prostate Cancer

NCT02635256

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Saphir Radiosurgery Center Frankfurt am Main Frankfurt am Main, Germany
  • University Hospital Frankfurt, Department of Radiation Therapy and Oncology Frankfurt am Main, Germany
  • Saphir Radiosurgery Center Northern Germany Güstrow, Germany
  • University Medical Center Schleswig-Holstein Kiel, Germany
View Trial Details
Completed

A Salvage Trial of AR Inhibition With ADT and Apalutamide With Radiation Therapy Followed by Docetaxel in Men With PSA Recurrent Prostate Cancer After Radical Prostatectomy (STARTAR)

NCT03311555

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • GU Research Network / Urology Cancer Center Omaha, Nebraska, United States
  • Weill Cornell Medical Center New York, United States
  • Duke Cancer Center Cary Cary, North Carolina, United States
  • Duke University Medical Center Durham, North Carolina, United States
View Trial Details

Related conditions